Terns Pharmaceuticals, INC. (TERN) SEC Filings — 2025

Filings

• Terns Pharmaceuticals Files 8-K — 8-K · Dec 11, 2025
• Terns Pharmaceuticals Files 8-K — 8-K · Dec 8, 2025
• Terns Pharma Widens Q3 Loss Amid Rising R&D Spend — 10-Q · Nov 10, 2025
• Terns Pharmaceuticals Files 8-K — 8-K · Nov 3, 2025
• Terns Pharmaceuticals Files 8-K — 8-K · Oct 22, 2025
• Terns Narrows Q2 Loss Amid R&D Cuts, Cash Runway to H2 2026 — 10-Q · Aug 5, 2025
• Terns Pharmaceuticals Reports Shareholder Vote Matter — 8-K · Jun 16, 2025
• Terns Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Terns Pharmaceuticals Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
• Terns Pharmaceuticals Files 2024 10-K — 10-K · Mar 20, 2025
• Terns Pharmaceuticals Appoints New Director — 8-K · Feb 24, 2025
• Terns Pharmaceuticals Files 8-K on Executive Changes — 8-K · Feb 20, 2025
• Terns Pharmaceuticals Announces Executive Changes and New Director — 8-K · Feb 6, 2025